Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study
- PMID: 25111081
- PMCID: PMC4260326
- DOI: 10.1097/QAD.0000000000000428
Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study
Abstract
Objective: HIV-infected people have greatly elevated risk of non-Hodgkin lymphoma (NHL), particularly the AIDS-defining NHL subtypes: diffuse large B-cell lymphoma, Burkitt lymphoma and primary lymphomas arising in the central nervous system. The goals of this analysis were to comprehensively describe risks of NHL subtypes, especially those not well studied, among HIV/AIDS patients; examine risks specifically in the HAART era; and distinguish risks in HIV-infected individuals prior to diagnosis with AIDS.
Design: Population-based registry linkage study.
Methods: We used data from the US HIV/AIDS Cancer Match Study from 1996 to 2010 (N = 273 705) to calculate standardized incidence ratios (SIRs) comparing subtype-specific NHL risks in HIV-infected people to those in the general population, and used Poisson regression to test for differences in SIRs between the HIV-only and AIDS periods.
Results: NHL risk was elevated 11-fold compared to the general population, but varied substantially by subtype. AIDS-defining NHL subtypes comprised the majority, and risks were high (SIRs ≥17), but risks were also increased for some T-cell lymphomas (SIRs = 3.6-14.2), marginal zone lymphoma (SIR = 2.4), lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (SIR = 3.6), and acute lymphoblastic leukemia/lymphoma (SIR = 2.4).
Conclusion: HIV-infected people in the HAART era continue to have elevated risk of AIDS-defining NHL subtypes, highlighting the contribution of moderate and severe immunosuppression to their cause. Whereas non-AIDS-defining subtypes are much less common, immunosuppression or other dysregulated immune states likely play a role in the cause of some T-cell lymphomas, marginal zone lymphoma, lymphoplasmacytic lymphoma/Waldenström macroglobulinemia, and acute lymphoblastic leukemia/lymphoma.
References
-
- Centers for Disease Control and Prevention Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 1987;36(Suppl 1):1S–15S. - PubMed
-
- Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. Study HACM. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962–972. - PubMed
-
- Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–194. - PubMed
-
- Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20:1645–1654. - PubMed
Publication types
MeSH terms
Grants and funding
- U58 DP003931/DP/NCCDPHP CDC HHS/United States
- 5U58DP000824-04/DP/NCCDPHP CDC HHS/United States
- 5U58DP003931-02/DP/NCCDPHP CDC HHS/United States
- U58 DP000848-04/DP/NCCDPHP CDC HHS/United States
- HHSN261201300021I/PHS HHS/United States
- Z99 CA999999/ImNIH/Intramural NIH HHS/United States
- 5U58DP003875-01/DP/NCCDPHP CDC HHS/United States
- N01PC-2013-00021/PC/NCI NIH HHS/United States
- U58 DP000824/DP/NCCDPHP CDC HHS/United States
- U58 DP003875/DP/NCCDPHP CDC HHS/United States
- 5U58DP000812-03/DP/NCCDPHP CDC HHS/United States
- U58 DP000848/DP/NCCDPHP CDC HHS/United States
- U58 DP000812/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical